GSK PLC Sponsored ADR (NYSE:GSK – Get Free Report) was the recipient of unusually large options trading on Thursday. Investors acquired 122,136 call options on the company. This is an increase of approximately 1,570% compared to the average volume of 7,312 call options. Analyst Ratings Changes A ... Read more
Bbns - Nov 13
Market Size and Growth:The Global Herpes Zoster Oticus Market Size reached US$ 12.3 million in 2024 and is expected to reach US$ 36.9 million by 2032, growing at a CAGR of 13.2% during the forecast period 2024-2032. The Market is Read more
Openpr.com - Nov 10
On Friday, the U.S. Food and Drug Administration (FDA) approved GSK Plc’s (NYSE:GSK) Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone (BVd) for adult patients with relapsed or refractory multiple myeloma who have received at least two prior lines of therapy.The... Read more
Benzinga - Oct 24
The FDA delivered a split decision on a blood cancer drug from GSK, approving its use in one combination regimen but rejecting another Read more
Stat - Oct 24
Acquisition follows GSK’s 2021 decision to sell its antibiotics business for up to $500 million Read more
The Times - Oct 20
CEO Emma Walmsley said GSK has had a minimal role in an effort by the FDA to update the prescribing information of the long-shelved drug leucovorin Read more
Stat - Oct 16
Health Secretary Robert F Kennedy Jr. could deliver a policy win for the Trump administration in just a few months after the Food and Drug Administration enlisted GSK to help it fast-track approval of a decades-old drug to treat an autism-related disorder. Read more
Home | Triblive.com - Oct 06
The pharma giants' multibillion spending promises come as drugmakers look to mitigate the threat of levies on imported medicines Read more
Quartz - Sep 17
The giant British pharmaceutical company is investing in advanced manufacturing facilities in the US Read more
The Times - Sep 16
